Akebia Therapeutics, Inc. (AKBA) Q2 2026 Earnings Call Transcript

SA Transcripts 161.54K Followers Follow Akebia Therapeutics, Inc. ( AKBA ) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDT Company Participants Mercedes Carrasco - Senior Director of Investor & Corporate Communications John Butler - CEO, President & Director Steven Burke - Senior VP and Chief Research & Development Officer Nicholas Grund - Senior VP & Chief Commercial Officer Erik Ostrowski - Chief Business Officer, Senior VP, CFO & Treasurer Conference Call Participants Matthew Caufield - H.C. Wainwright & Co, LLC, Research Division Andrew Kassin - BTIG, LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. This is Roy, and I will be your conference operator today. At this time, I would like to welcome everyone to the Akebia's Second Quarter 202 Financial Results. [Operator Instructions] I would now like to turn the conference over to Mercedes Carrasco. Please go ahead. Mercedes Carrasco Senior Director of Investor & Corporate Communications Thank you, and welcome to Akebia's Second Quarter 2026 Financial Results and Business Update Conference Call. Please note that a press release was issued earlier today, Wednesday, August 5, detailing our second quarter 2026 financial results, and that release is available on the Investors section of our website. For your convenience, a replay of today's call will also be available on our website after we conclude. Joining me today, we have John Butler, Chief Executive Officer; Dr. Steven Burke, our Chief Medical Officer; Nick Grund, our Chief Commercial Officer; and Erik Ostrowski, Chief Financial and Chief Business Officer. I'd like to remind everyone that this call includes forward-looking statements. Each forward-looking statement on this call is subject to risks and uncertainties that could cause actual results to differ materially from those described in these statements. Additional information describing these risks is included in the financial results press release that we issued on August 5 as